Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients: A Randomized Controlled Trial
Eggensberger OHG
30 participants
Dec 1, 2025
INTERVENTIONAL
Conditions
Summary
This randomized controlled study evaluates the effects of cold water hydrotherapy in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to an usual care setting without hydrotherapy treatment.
Eligibility
Inclusion Criteria4
- Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9)
- Barthel-Index \>80
- Owning a smartphone to receive digital questionnaires and to use the measurement app for heart rate variability
- Written informed consent
Exclusion Criteria2
- Existing contraindications for Kneipp hydrotherapy like severe cardiovascular diseases (e.g., decompensated heart failure, unstable angina pectoris, acute myocardial infarction), severe venous diseases (e.g., acute deep vein thrombosis of the leg), severe neurological diseases (e.g., uncontrolled epilepsy)
- Prior regular practice of Kneipp applications
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Cold water hydrotherapy (5-10 minutes each), four times daily during the 3-week program and once daily during the 6-month follow-up period. Hydrotherapy interventions are individually tailored to each subject based on their responses and include various washing and pouring techniques.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07110714